Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Inflection Point Acquisition II Unit | IPXXU | Jun 14, 2024 | 10.57 | -0.09 |
Infobird | IFBD | Jun 14, 2024 | 3.25 | -4.13 |
Informatica | INFA | Jun 14, 2024 | 29.66 | +0.34 |
Information Services Group | III | Jun 14, 2024 | 3.10 | -2.21 |
Information Technology ETF Vanguard | VGT | Jun 14, 2024 | 579.41 | +0.39 |
Infosys ADR | INFY | Jun 14, 2024 | 17.79 | -0.11 |
InfuSystems | INFU | Jun 14, 2024 | 6.61 | -0.90 |
ING Group ADR | ING | Jun 14, 2024 | 16.40 | -1.86 |
Ingersoll Rand | IR | Jun 14, 2024 | 91.46 | -3.17 |
Ingevity | NGVT | Jun 14, 2024 | 44.91 | -2.16 |
Ingles Markets A | IMKTA | Jun 14, 2024 | 68.32 | +0.01 |
Ingredion | INGR | Jun 14, 2024 | 113.89 | -0.75 |
Inhibikase Therapeutics | IKT | Jun 14, 2024 | 1.41 | -7.84 |
Inhibrx Biosciences | INBX | Jun 14, 2024 | 15.70 | -5.36 |
InMed | INM | Jun 14, 2024 | 0.23 | -4.55 |
InMode | INMD | Jun 14, 2024 | 18.24 | +0.22 |
INmune Bio | INMB | Jun 14, 2024 | 8.49 | -6.50 |
Innate Pharma ADR | IPHA | Jun 14, 2024 | 2.35 | -0.86 |
Inno Holdings | INHD | Jun 14, 2024 | 0.71 | +5.97 |
Innodata | INOD | Jun 14, 2024 | 15.15 | -3.13 |
Innospec | IOSP | Jun 14, 2024 | 122.91 | -2.09 |
InnovAge | INNV | Jun 14, 2024 | 5.08 | -1.17 |
Innovate | VATE | Jun 14, 2024 | 0.62 | -2.62 |
Innovative Eyewear | LUCY | Jun 14, 2024 | 0.42 | -4.73 |
Innovative Industrial Properties | IIPR | Jun 14, 2024 | 106.62 | +0.33 |
Innovative Industrial Properties A Pref | IIPR-A | Jun 14, 2024 | 27.69 | 0.00 |
Innovative Solutions and Support | ISSC | Jun 14, 2024 | 6.24 | -0.95 |
Innovid | CTV | Jun 14, 2024 | 1.89 | -2.07 |
Innoviva | INVA | Jun 14, 2024 | 15.91 | -0.50 |
Innoviz Technologies | INVZ | Jun 14, 2024 | 0.98 | -1.09 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.